9IRY

Structure of human URAT1 bound with verinurad

これはPDB形式変換不可エントリーです。

9IRY の概要

• エントリーDOI: 10.2210/pdb9iry/pdb
• EMDBエントリー: 60825
• 分子名称: Solute carrier family 22 member 12, verinurad (2 entities in total)
• 機能のキーワード: slc22, urate, gout, verinurad, transport protein
• 由来する生物種: Homo sapiens (human)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 59895.02

構造登録者

Guo, W.J.,Wei, M.,Chen, L. (登録日: 2024-07-16, 公開日: 2025-01-15, 最終更新日: 2025-05-07)

主引用文献

Guo, W.,Wei, M.,Li, Y.,Xu, J.,Zang, J.,Chen, Y.,Chen, L.
Mechanisms of urate transport and uricosuric drugs inhibition in human URAT1.
Nat Commun, 16:1512-1512, 2025

PubMed Abstract: High urate levels in circulation lead to the accumulation of urate crystals in joints and ultimately inflammation and gout. The reabsorption process of urate in the kidney by the urate transporter URAT1 plays a pivotal role in controlling serum urate levels. Pharmacological inhibition of URAT1 by uricosuric drugs is a valid strategy for gout management. Despite the clinical significance of URAT1, its structural mechanism and dynamics remain incompletely understood. Here, we report the structures of human URAT1 (hURAT1) in complex with substrate urate or inhibitors benzbromarone and verinurad at resolution ranges from 3.0 to 3.3 Å. We observe urate in the central substrate-binding site of hURAT1 in the outward-facing conformation and urate is wrapped in the center of hURAT1 by five phenylalanines and coordinated by two positively charged residues on each side. Uricosuric compounds benzbromarone and verinurad occupy the urate-binding site of hURAT1 in the inward-facing conformation. Structural comparison between different conformations of hURAT1 reveals the rocker-switch-like mechanism for urate transport. Benzbromarone and verinurad exert their inhibitory effect by blocking not only the binding of urate but also the structural isomerization of hURAT1.

PubMed: 39929841
DOI: 10.1038/s41467-025-56843-5

実験手法

ELECTRON MICROSCOPY (3.2 Å)